Marcus Low
Impact in
- Infectious Diseases top 5%
- Tuberculosis Research and Epidemiology
- HIV/AIDS drug development and treatment
- Virology top 10%
- HIV Research and Treatment
Papers in
-
- Tuberculosis Research and Epidemiology 4
- HIV/AIDS Research and Interventions 3
- HIV/AIDS drug development and treatment 3
-
- HIV-related health complications and treatments 2
- Co-authors
- Miklós Nagy (2 shared papers)Sándor Gǒrög (2 shared papers)Rudi Pauwels (2 shared papers)Masanori Baba (2 shared papers)Erik De Clercq (2 shared papers)Dominique Schols (2 shared papers)Steven G. Morgan (1 shared paper)Fátima Suleman (1 shared paper)
- Journals
- The Lancet Respiratory Medicine (2 papers)BMJ (1 paper)Public Health Action (1 paper)Bulletin of the World Health Organization (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)
- Partner nations
- South AfricaUnited StatesNetherlands
In The Last Decade
Marcus Low
10 papers receiving 829 citations
Marcus Low's Hit Papers
Peers
Comparison fields: 5 of 90
- Infectious Diseases 569
- Virology 63
- Epidemiology 352
- Molecular Medicine 41
- Applied Microbiology and Biotechnology 9
Countries citing papers authored by Marcus Low
This map shows the geographic impact of Marcus Low's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus Low with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus Low more than expected).
Fields of papers citing papers by Marcus Low
This network shows the impact of papers produced by Marcus Low. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus Low. The network helps show where Marcus Low may publish in the future.
Co-authors
The 25 scholars most cited alongside Marcus Low, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis Hit paper breakdown → | 2017 | 510 |
| 2 | 1990 | 99 | |
| 3 | 2019 | 94 | |
| 4 | 1990 | 87 | |
| 5 | 2020 | 32 | |
| 6 | 2023 | 9 | |
| 7 | 2017 | 7 | |
| 8 | 2017 | 7 | |
| 9 | 2014 | 4 | |
| 10 | 2014 | 3 |
About Marcus Low
Marcus Low is a scholar working on Infectious Diseases, Emergency Medicine, Epidemiology, Virology and Molecular Medicine, having authored 10 papers that have together received 852 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (4 papers), HIV/AIDS Research and Interventions (3 papers), HIV/AIDS drug development and treatment (3 papers), Mycobacterium research and diagnosis (2 papers), HIV-related health complications and treatments (2 papers), Biotechnology and Related Fields (2 papers), Pharmaceutical Economics and Policy (2 papers) and Diagnosis and treatment of tuberculosis (1 paper). The work is most often cited by research in Infectious Diseases (569 citations), Virology (63 citations), Epidemiology (352 citations), Molecular Medicine (41 citations) and Applied Microbiology and Biotechnology (9 citations). Marcus Low has collaborated with scholars based in South Africa, United States and Netherlands. Frequent co-authors include Miklós Nagy, Sándor Gǒrög, Rudi Pauwels, Masanori Baba, Erik De Clercq, Dominique Schols, Steven G. Morgan, Fátima Suleman, Suerie Moon and Raymund Machovich. Their work appears in journals such as The Lancet Respiratory Medicine, BMJ, Public Health Action, Bulletin of the World Health Organization and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.